Off-Label Pharmacovigilance

被引：1

作者：

Edwards, I. Ralph ^{[1
]}

机构：

[1] Uppsala Monitoring Ctr, SE-75140 Uppsala, Sweden

来源：

关键词：

D O I：

10.2165/11596140-000000000-00000

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：795 / 797

页数：3

共 50 条

[1] Off-Label Pharmacovigilance
I. Ralph Edwards
[J]. Drug Safety, 2011, 34 : 795 - 797
[2] PHARMACOVIGILANCE TREND ANALYSIS OF MEDICATION OFF-LABEL USE
Ali, A. K.
[J]. VALUE IN HEALTH, 2016, 19 (03) : A274 - A274
[3] Off-label use of antipsychotics: Rethinking "off-label"
Groleger, Urban
[J]. PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
[4] Off-Label
Cox, John V.
[J]. JOURNAL OF ONCOLOGY PRACTICE, 2011, 7 (02) : 69 - 69
[5] Off-label prescription
Srinivasan, S
[J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2004, 17 (04): : 229 - 229
[6] Off-label promotion
Kuehn, BM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (06): : 673 - 673
[7] Off-label prescribing
Raknes, Guttorm
[J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (04) : 335 - 335
[8] The "Off-label" TAVI
Kornowski, Ran
[J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (08): : 443 - 444
[9] Off-label use of intravitreal bevacizumab at a national hospital in Peru: An active pharmacovigilance experience
Rodriguez, Yesenia
Romero, Denys
Fernandez, Paola
Saromo, Violeta
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 512 - 512
[10] Off-label perils
不详
[J]. COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 2004, 26 (11): : 834 - 834